Search Results - "Tan, Var"

Refine Results
  1. 1

    Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice by Abad, Catalina, Tan, Yossan-Var

    Published in Journal of molecular neuroscience (01-09-2018)
    “…A bidirectional cross-talk is established between the nervous and immune systems through common mediators including neuropeptides, neurotransmitters, and…”
    Get full text
    Journal Article
  2. 2

    Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases by Couvineau, Alain, Voisin, Thierry, Nicole, Pascal, Gratio, Valérie, Abad, Catalina, Tan, Yossan-Var

    Published in Frontiers in endocrinology (Lausanne) (22-10-2019)
    “…Orexins [orexin-A (OXA) and orexin-B (OXB)] are two isoforms of neuropeptides produced by the hypothalamus. The main biological actions of orexins, focused on…”
    Get full text
    Journal Article
  3. 3

    Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation by Becquet, Laurine, Abad, Catalina, Leclercq, Mathilde, Miel, Camille, Jean, Laetitia, Riou, Gaëtan, Couvineau, Alain, Boyer, Olivier, Tan, Yossan-Var

    Published in Journal of neuroinflammation (20-03-2019)
    “…Orexins (hypocretins, Hcrt) A and B are GPCR-binding hypothalamic neuropeptides known to regulate sleep/wake states and feeding behavior. A few studies have…”
    Get full text
    Journal Article
  4. 4

    Class II G protein-coupled receptors for VIP and PACAP: Structure, models of activation and pharmacology by Laburthe, Marc, Couvineau, Alain, Tan, Var

    Published in Peptides (New York, N.Y. : 1980) (01-09-2007)
    “…VIP and PACAP impact strongly on human pathophysiology. Their receptors are very promising targets for developing new drugs in the treatment of inflammatory…”
    Get full text
    Journal Article
  5. 5

    Calcium signaling via Orai1 is essential for induction of the nuclear orphan receptor pathway to drive Th17 differentiation by Kim, Kyun-Do, Srikanth, Sonal, Tan, Yossan-Var, Yee, Ma-Khin, Jew, Marcus, Damoiseaux, Robert, Jung, Michael E, Shimizu, Saki, An, Dong Sung, Ribalet, Bernard, Waschek, James A, Gwack, Yousang

    Published in The Journal of immunology (1950) (01-01-2014)
    “…Orai1 is the pore subunit of Ca(2+) release-activated Ca(2+) (CRAC) channels that stimulate downstream signaling pathways crucial for T cell activation. CRAC…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis by Tan, Yossan-Var, Abad, Catalina, Lopez, Robert, Dong, Hongmei, Liu, Shen, Lee, Alice, Gomariz, Rosa P, Leceta, Javier, Waschek, James A

    “…Pituitary adenylyl cyclase-activating polypeptide (PACAP) is a widely expressed neuropeptide originally discovered in the hypothalamus. It closely resembles…”
    Get full text
    Journal Article
  10. 10
  11. 11

    VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses by Abad, Catalina, Tan, Yossan-Var, Cheung-Lau, Gardenia, Nobuta, Hiroko, Waschek, James A

    Published in PloS one (17-05-2012)
    “…Vasoactive intestinal peptide (VIP) is a pleiotropic neuropeptide with immunomodulatory properties. The administration of this peptide has been shown to have…”
    Get full text
    Journal Article
  12. 12

    Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE by Tan, Yossan-Var, Abad, Catalina, Wang, Yuqi, Lopez, Robert, Waschek, James A

    Published in PloS one (16-04-2013)
    “…We have shown that mice deficient in pituitary adenylate cyclase-activating polypeptide (PACAP, gene name ADCYAP1) manifest enhanced sensitivity to…”
    Get full text
    Journal Article
  13. 13

    Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis by Tan, Yossan-Var, Waschek, James A

    Published in ASN neuro (06-10-2011)
    “…MS (multiple sclerosis) is a chronic autoimmune and neurodegenerative pathology of the CNS (central nervous system) affecting approx. 2.5 million people…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Correction: VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses by Abad, Catalina, Tan, Yossan-Var, Cheung-Lau, Gardenia, Nobuta, Hiroko, Waschek, James A.

    Published in PloS one (12-06-2013)
    “…The following sentence was incorrectly cited: "Interestingly, Yadav et al have recently shown that VPAC1 KO mice present milder DSS-induced colitis compared to…”
    Get full text
    Journal Article
  16. 16

    Diffuse Pharmacophoric Domains of Vasoactive Intestinal Peptide (VIP) and Further Insights into the Interaction of VIP with the N-terminal Ectodomain of Human VPAC1 Receptor by Photoaffinity Labeling with [Bpa6]-VIP by Tan, Yossan-Var, Couvineau, Alain, Laburthe, Marc

    Published in The Journal of biological chemistry (10-09-2004)
    “…The widespread 28-amino acid neuropeptide vasoactive intestinal peptide (VIP) exerts its many biological effects through interaction with serpentine class II G…”
    Get full text
    Journal Article
  17. 17

    Photoaffinity Labeling Demonstrates Physical Contact between Vasoactive Intestinal Peptide and the N-terminal Ectodomain of the Human VPAC1 Receptor by Tan, Yossan-Var, Couvineau, Alain, Van Rampelbergh, Jean, Laburthe, Marc

    Published in The Journal of biological chemistry (19-09-2003)
    “…Vasoactive intestinal peptide (VIP) is a prominent neuropeptide whose actions are mediated by VPAC receptors belonging to class II G protein-coupled receptors…”
    Get full text
    Journal Article
  18. 18
  19. 19

    VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses by Tan, Yossan-Var, Abad, Catalina, Wang, Yuqi, Lopez, Robert, Waschek, James A

    Published in Brain, behavior, and immunity (01-02-2015)
    “…Highlights • Loss of VPAC2 receptor results in exacerbated EAE. • Th1 and Th17 responses were enhanced and Th2 diminished in VPAC2 KO mice with EAE. • VPAC2 KO…”
    Get full text
    Journal Article
  20. 20